Resultado de búsqueda
Track TG Therapeutics Inc (TGTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
16 de abr. de 2024 · Discover real-time TG Therapeutics, Inc. Common Stock (TGTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
5 de may. de 2024 · Get real-time updates on TG Therapeutics, Inc. Common Stock (TGTX) stock quotes, trades, and more. Make informed investments with Nasdaq.
29 de dic. de 2022 · Wednesday, the FDA approved TG Therapeutics Inc's (NASDAQ: TGTX) Briumvi (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS). Briumvi is the first and only anti-CD20 monoclonal ...
TGTX Its a point where it can go buy from, but its a weak price point at $17 - $18. it has to show me a reversal pattern to consider buying from those prices. The best situation is if the price decreases to around $13 - $14 to buy until $25 that's 80% growth. by ImSoloInvestor.
Hace 6 días · 284. Mike Weiss. www.tgtherapeutics.com. TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult ...
28 de dic. de 2022 · B-cell disorders. TG-1801: anti-CD47/CD19 bispecific mAb. B-cell disorders. TG-1701: BTK inhibitor. B-cell disorders. The safety and efficacy of our investigational compounds and investigational uses of approved products have not been established.
